Abstract
Diseases caused by protozoans and helminthes are some of the most common afflicting humans around the world, and yet they are some of the most scientifically neglected regarding their pathogenesis, diagnosis, and treatment. In this chapter, principles of molecular pathogenesis of the most common protozoan and helminth infections are discussed. Emphasis is placed on immunopathology (innate and adaptive immune responses), parasitic proteases, and immunomodulation by parasites. Selected protozoan and helminth infections are discussed in detail.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Pearce EJ, Tarleton RL. Overview of parasitic pathogens. In: Kaufmann SHE, Sher A, Ahmed R, editors. Immunology of infectious diseases. 1st ed. Washington, DC: ASM Press; 2002. p. 39–52.
Brindley PJ, Mitreva M, Ghedin E, Lustigman S. Helminth genomics: the implications for human health. PLoS Negl Trop Dis. 2009;3:e538.
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–57.
Scott P, Grencis RK. Adaptive immune effector mechanisms against intracellular protozoa and gut-dwelling nematodes. In: Kaufmann SHE, Sher A, Ahmed R, editors. Immunology of infectious diseases. Washington, DC: ASM Press; 2002. p. 235–46.
Gazzinelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol. 1996;157:798–805.
Bessieres MH, Swierczynski B, Cassaing S, et al. Role of IFN-gamma, TNF-alpha, IL4 and IL10 in the regulation of experimental Toxoplasma gondii infection. J Eukaryot Microbiol. 1997;44:87S.
Butcher BA, Kim L, Panopoulos AD, Watowich SS, Murray PJ, Denkers EY. IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages. J Immunol. 2005;174:3148–52.
Dunne DW, Pearce EJ. Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect. 1999;1:553–60.
Cheever AW, Yap GS. Immunologic basis of disease and disease regulation in schistosomiasis. Chem Immunol. 1997;66:159–76.
Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol. 2007;85:148–54.
Chiaramonte MG, Schopf LR, Neben TY, Cheever AW, Donaldson DD, Wynn TA. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol. 1999;162:920–30.
Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev. 2004;201:156–67.
Norris KA, Schrimpf JE. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi. Infect Immun. 1994;62:236–43.
Reed SL, Ember JA, Herdman DS, DiScipio RG, Hugli TE, Gigli I. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J Immunol. 1995;155:266–74.
Pearce EJ, Hall BF, Sher A. Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor. J Immunol. 1990;144:2751–6.
Da Silva RP, Hall BF, Joiner KA, Sacks DL. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol. 1989;143:617–22.
Andrews NW, Abrams CK, Slatin SL, Griffiths G. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell. 1990;61:1277–87.
Sibley LD, Weidner E, Krahenbuhl JL. Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature. 1985;315:416–9.
Nebl T, De Veer MJ, Schofield L. Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors. Parasitology. 2005;130(Suppl):S45–62.
Ropert C, Ferreira LR, Campos MA, et al. Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. Microbes Infect. 2002;4:1015–25.
Proudfoot L, O’Donnell CA, Liew FY. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur J Immunol. 1995;25:745–50.
Carrera L, Gazzinelli RT, Badolato R, et al. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med. 1996;183:515–26.
Hunter CA, Sher A. Innate immunity to parasitic infections. In: Kaufmann SHE, Sher A, Ahmed R, editors. Immunology of infectious diseases. Washington, DC: ASM Press; 2002. p. 111–27.
Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol. 1998;70:83–243.
Aliberti J, Reis-e-Sousa C, Schito M, et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat Immunol. 2000;1:83–7.
Soong L, Xu JC, Grewal IS, et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 1996;4:263–73.
Finkelman FD, Shea-Donohue T, Goldhill J, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol. 1997;15:505–33.
Donaldson LE, Schmitt E, Huntley JF, Newlands GF, Grencis RK. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int Immunol. 1996;8:559–67.
Grencis RK, Entwistle GM. Production of an interferon-gamma homologue by an intestinal nematode: functionally significant or interesting artefact? Parasitology. 1997;115(Suppl):S101–6.
Diaz A, Allen JE. Mapping immune response profiles: the emerging scenario from helminth immunology. Eur J Immunol. 2007;37:3319–26.
Anthony RM, Rutitzky LI, Urban Jr JF, Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nat Rev Immunol. 2007;7:975–87.
Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science. 2002;296:490–4.
Lepenies B, Jacobs T. The role of negative costimulators during parasitic infections. Endocr Metab Immune Disord Drug Targets. 2008;8:279–88.
Johnston MJ, MacDonald JA, McKay DM. Parasitic helminths: a pharmacopeia of anti-inflammatory molecules. Parasitology. 2009;136:125–47.
Robinson MW, Dalton JP, Donnelly S. Helminth pathogen cathepsin proteases: it’s a family affair. Trends Biochem Sci. 2008;33:601–8.
Hewitson JP, Grainger JR, Maizels RM. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol. 2009;167:1–11.
Tort J, Brindley PJ, Knox D, Wolfe KH, Dalton JP. Proteinases and associated genes of parasitic helminths. Adv Parasitol. 1999;43:161–266.
Lackey A, James ER, Sakanari JA, et al. Extracellular proteases of Onchocerca. Exp Parasitol. 1989;68:176–85.
Park H, Kim SI, Hong KM, et al. Characterization and classification of five cysteine proteinases expressed by Paragonimus westermani adult worm. Exp Parasitol. 2002;102:143–9.
Na BK, Lee HJ, Cho SH, et al. Expression of cysteine proteinase of Clonorchis sinensis and its use in serodiagnosis of clonorchiasis. J Parasitol. 2002;88:1000–6.
Shin MH, Lee SY. Proteolytic activity of cysteine protease in excretory-secretory product of Paragonimus westermani newly excysted metacercariae pivotally regulates IL-8 production of human eosinophils. Parasite Immunol. 2000;22:529–33.
Curwen RS, Wilson RA. Invasion of skin by schistosome cercariae: some neglected facts. Trends Parasitol. 2003;19:63–6; discussion 66–8 [see comment].
McKerrow JH, Caffrey C, Kelly B, Loke P, Sajid M. Proteases in parasitic diseases. Ann Rev Pathol Mechan Dis. 2006;1:497–536.
Hartmann S, Lucius R. Modulation of host immune responses by nematode cystatins. Int J Parasitol. 2003;33:1291–302.
Manoury B, Gregory WF, Maizels RM, Watts C. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol. 2001;11:447–51.
Silverman GA, Bird PI, Carrell RW, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 2001;276:33293–6.
Bruchhaus I, Jacobs T, Leippe M, Tannich E. Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes. Mol Microbiol. 1996;22:255–63.
Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005;6:41–61.
Dobrowolski JM, Sibley LD. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell. 1996;84:933–9.
Soldati-Favre D. Molecular dissection of host cell invasion by the apicomplexans: the glideosome. Parasite. 2008;15:197–205.
Sibley LD. Intracellular parasite invasion strategies. Science. 2004;304:248–53.
Dowse T, Soldati D. Host cell invasion by the apicomplexans: the significance of microneme protein proteolysis. Curr Opin Microbiol. 2004;7:388–96.
Meissner M, Schluter D, Soldati D. Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science. 2002;298:837–40.
Lovett JL, Marchesini N, Moreno SN, Sibley LD. Toxoplasma gondii microneme secretion involves intracellular Ca(2+) release from inositol 1,4,5-triphosphate (IP(3))/ryanodine-sensitive stores. J Biol Chem. 2002;277:25870–6.
Sinai AP, Joiner KA. The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane. J Cell Biol. 2001;154:95–108.
Aliberti J, Jankovic D, Sher A. Turning it on and off: regulation of dendritic cell function in Toxoplasma gondii infection. Immunol Rev. 2004;201:26–34.
Sher A, Collazzo C, Scanga C, Jankovic D, Yap G, Aliberti J. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii. Immunol Res. 2003;27:521–8.
Fadul CE, Channon JY, Kasper LH. Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes. Infect Immun. 1995;63:4290–4.
Eichinger D. A role for a galactose lectin and its ligands during encystment of Entamoeba. J Eukaryot Microbiol. 2001;48:17–21.
Reed SL, Gigli I. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase. J Clin Invest. 1990;86:1815–22.
Ravdin JI, Moreau F, Sullivan JA, Petri Jr WA, Mandell GL. Relationship of free intracellular calcium to the cytolytic activity of Entamoeba histolytica. Infect Immun. 1988;56:1505–12.
Haque R, Ali IM, Sack RB, Farr BM, Ramakrishnan G, Petri Jr WA. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis. 2001;183:1787–93.
Salata RA, Martinez-Palomo A, Murray HW, et al. Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. J Immunol. 1986;136:2633–9.
Denis M, Chadee K. Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro. J Leukoc Biol. 1989;46:270–4.
Weiss LM, Schwartz DA. Microsporidiosis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. 2nd ed. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1126–40.
Xu Y, Weiss LM. The microsporidian polar tube: a highly specialised invasion organelle. Int J Parasitol. 2005;35:941–53.
Xu Y, Takvorian PM, Cali A, Orr G, Weiss LM. Glycosylation of the major polar tube protein of Encephalitozoon hellem, a microsporidian parasite that infects humans. Infect Immun. 2004;72:6341–50.
Peek R, Delbac F, Speijer D, et al. Carbohydrate moieties of microsporidian polar tube proteins are targeted by immunoglobulin G in immunocompetent individuals. Infect Immun. 2005;73:7906–13.
Peuvel I, Peyret P, Metenier G, Vivares CP, Delbac F. The microsporidian polar tube: evidence for a third polar tube protein (PTP3) in Encephalitozoon cuniculi. Mol Biochem Parasitol. 2002;122:69–80.
Franzen C, Muller A, Hartmann P, Salzberger B. Cell invasion and intracellular fate of Encephalitozoon cuniculi (Microsporidia). Parasitology. 2005;130:285–92.
Scanlon M, Shaw AP, Zhou CJ, Visvesvara GS, Leitch GJ. Infection by microsporidia disrupts the host cell cycle. J Eukaryot Microbiol. 2000;47:525–31.
Mac Kenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med. 1994;331:161–7 [see comment] [erratum appears in N Engl J Med. 1994;331(15):1035].
Bushen OY, Lima AAM, Guerrant RL. Cryptosporidiosis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. 2nd ed. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1003–14.
Kirkpatrick BD, Daniels MM, Jean SS, et al. Cryptosporidiosis stimulates an inflammatory intestinal response in malnourished Haitian children. J Infect Dis. 2002;186:94–101.
Argenzio RA, Rhoads JM, Armstrong M, Gomez G. Glutamine stimulates prostaglandin-sensitive Na(+)-H+ exchange in experimental porcine cryptosporidiosis. Gastroenterology. 1994;106:1418–28 [see comment].
Kandil HM, Berschneider HM, Argenzio RA. Tumour necrosis factor alpha changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut. 1994;35:934–40.
Seydel KB, Zhang T, Champion GA, et al. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infect Immun. 1998;66:2379–82.
Robinson P, Okhuysen PC, Chappell CL, et al. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis. 2003;188:290–6.
Hashim A, Mulcahy G, Bourke B, Clyne M. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells. Infect Immun. 2006;74:99–107.
Abrahamsen MS, Templeton TJ, Enomoto S, et al. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science. 2004;304:441–5.
White AC, Robinson P, Okhuysen PC, et al. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J Infect Dis. 2000;181:701–9.
Robinson P, Okhuysen PC, Chappell CL, et al. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection. Cytokine. 2001;15:39–46.
Nutman TB, Kazura JW. Filariasis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1152–62.
Babu S, Nutman TB. Proinflammatory cytokines dominate the early immune response to filarial parasites. J Immunol. 2003;171:6723–32.
Graham SP, Trees AJ, Collins RA, et al. Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis. Infect Immun. 2001;69:4313–9.
Steel C, Nutman TB. CTLA-4 in filarial infections: implications for a role in diminished T cell reactivity. J Immunol. 2003;170:1930–8.
King CL, Mahanty S, Kumaraswami V, et al. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest. 1993;92:1667–73.
Hise AG, Gillette-Ferguson I, Pearlman E. The role of endosymbiotic Wolbachia bacteria in filarial disease. Cell Microbiol. 2004;6:97–104.
Taylor MJ. A new insight into the pathogenesis of filarial disease. Curr Mol Med. 2002;2:299–302.
Taylor MJ, Cross HF, Bilo K. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J Exp Med. 2000;191:1429–36.
Eberhard ML. Zoonotic filariasis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1189–203.
Theis JH. Public health aspects of dirofilariasis in the United States. Vet Parasitol. 2005;133:157–80.
Siddiqui AA, Genta RM, Berk LB. Strongyloidiasis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1274–85.
Ashton FT, Li J, Schad GA. Chemo- and thermosensory neurons: structure and function in animal parasitic nematodes. Vet Parasitol. 1999;84:297–316.
Gomez Gallego S, Loukas A, Slade RW, et al. Identification of an astacin-like metallo-proteinase transcript from the infective larvae of Strongyloides stercoralis. Parasitol Int. 2005;54:123–33.
Genta RM. Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev. 1992;5:345–55.
Escobedo G, Roberts CW, Carrero JC, Morales-Montor J. Parasite regulation by host hormones: an old mechanism of host exploitation? Trends Parasitol. 2005;21:588–93.
Siddiqui AA, Stanley CS, Berk SL. A cDNA encoding the highly immunodominant antigen of Strongyloides stercoralis: gamma-subunit of isocitrate dehydrogenase (NAD+). Parasitol Res. 2000;86:279–83.
Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol. 2004;26:487–97.
Gabet AS, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000;19:4954–60.
Velez ID, Ortega JE, Velasquez LE. Paragonimiasis: a view from Colombia. Clin Chest Med. 2002;23:421–31.
Maclean JD, Cross J, Mahanty S. Liver, lung, and intestinal fluke infections. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1349–69.
Lee EG, Na BK, Bae YA, et al. Identification of immunodominant excretory-secretory cysteine proteases of adult Paragonimus westermani by proteome analysis. Proteomics. 2006;6:1290–300.
Jin Y, Lee JC, Choi IY, Kim EA, Shin MH, Kim WK. Excretory-secretory products produced by Paragonimus westermani differentially regulate the nitric oxide production and viability of microglial cells. Int Arch Allergy Immunol. 2006;139:16–24.
Shin MH, Chung YB, Kita H. Degranulation of human eosinophils induced by Paragonimus westermani-secreted protease. Korean J Parasitol. 2005;43:33–7.
Min DY, Lee YA, Ryu JS, et al. Caspase-3-mediated apoptosis of human eosinophils by the tissue-invading helminth Paragonimus westermani. Int Arch Allergy Immunol. 2004;133:357–64.
Li AH, Na BK, Kong Y, Cho SH, Zhao QP, Kim TS. Molecular cloning and characterization of copper/zinc-superoxide dismutase of Paragonimus westermani. J Parasitol. 2005;91:293–9.
Matsumoto N, Mukae H, Nakamura-Uchiyama F, et al. Elevated levels of thymus and activation-regulated chemokine (TARC) in pleural effusion samples from patients infested with Paragonimus westermani. Clin Exp Immunol. 2002;130:314–8.
Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002;346:1212–20 [see comment].
King CH. Schistosomiasis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1341–8.
King CH. Acute and chronic schistosomiasis. Hosp Pract (Office Edition). 1991;26:117–30.
Cheever AW. Schistosomiasis. Infection versus disease and hypersensitivity versus immunity. Am J Pathol. 1993;142:699–702.
Jankovic D, Kullberg MC, Noben-Trauth N, et al. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol. 1999;163:337–42.
Hokke CH, Yazdanbakhsh M. Schistosome glycans and innate immunity. Parasite Immunol. 2005;27:257–64.
Stadecker MJ, Asahi H, Finger E, Hernandez HJ, Rutitzky LI, Sun J. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev. 2004;201:168–79.
Berriman M, Haas BJ, LoVerde PT, et al. The genome of the blood fluke Schistosoma mansoni. Nature. 2009;460:352–8.
Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium, Zhou Y, et al. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature. 2009;460:345–51.
Thompson RC, McManus DP. Towards a taxonomic revision of the genus Echinococcus. Trends Parasitol. 2002;18:452–7.
Schantz PM, Kern P, Brunetti E. Echinococcosis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier/Churchill Livingstone; 2006. p. 1304–26.
Olano JP. Chapter 42: Parasites. In: Zander DS, Popper H, Jagirdar J, Cagle PT, Barrios R, editors. Molecular pathology of lung diseases. New York: Springer; 2008.
Acknowledgment
Sections of this chapter are reprinted with permission from Olano JP. Parasites. In: Zander DS, Popper H, Jagirdar J, Cagle PT, Barrios R, eds. Molecular Pathology of Lung Diseases. New York, NY: Springer; 2008:chap 42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Olano, J.P. (2013). Molecular Pathology of Pulmonary Parasitic Diseases. In: Barrios, R., Haque, A. (eds) Parasitic Diseases of the Lungs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37609-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-37609-2_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37608-5
Online ISBN: 978-3-642-37609-2
eBook Packages: MedicineMedicine (R0)